Status:
NOT_YET_RECRUITING
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Gastroenteritis
Eligibility:
All Genders
18-60 years
Brief Summary
Define the prevalence of fecal phage carriage in individuals with digestive symptoms (i) Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (d...
Eligibility Criteria
Inclusion
- Age between 18 and 60.
- Persons having developed gastrointestinal symptoms justifying microbiological stool testing at the time of hospitalization.
- Person having received full information on the organization of the research and not having objected to the use of this data
Exclusion
- Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the French Public Health Code.
- Pregnant or breast-feeding women,
- Minors (not emancipated),
- Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice),
- Persons of full age who are unable to give their consent.
- Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care by virtue of articles L. 3212-1 and L. 3213-1.
Key Trial Info
Start Date :
November 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 15 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06524791
Start Date
November 15 2024
End Date
November 15 2025
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Nancy, France, 54000